# Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women

> **NCT01653743** · PHASE3 · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 81 (actual)

## Conditions studied

- Anovulation
- Oligo-ovulation
- Hypothalamic-pituitary Dysfunction
- Polycystic Ovarian Syndrome

## Interventions

- **DRUG:** MSJ-0011
- **DRUG:** urinary hCG (u-hCG)
- **DRUG:** Follitropin alpha

## Key facts

- **NCT ID:** NCT01653743
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2014-11
- **Final completion:** 2014-12
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2016-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01653743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01653743, "Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01653743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*